Evidence map›Paper›PMID 16885182›Full record

Trial reportBMJ (Clinical research ed.)2006

Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): randomised controlled trial.

Marlene Fransen, Craig Anderson, Jan Douglas, Stephen MacMahon, Bruce Neal, Robyn Norton, Mark Woodward, Ian D Cameron, Ross Crawford, Sing Kai Lo and 3 more

Registry-linked trialOpen access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMJ (Clinical research ed.), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00145730 (A Multicentre Randomised Placebo-Controlled Trail of Ibuprofen for the Prevention of Ectopic Bone-Related Pain and Disability After Elective Hip Replacement Surgery), which is not on this map. Cited by 31 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 5 pooled it
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00145730 phase4completednot on this map

A Multicentre Randomised Placebo-Controlled Trail of Ibuprofen for the Prevention of Ectopic Bone-Related Pain and Disability After Elective Hip Replacement Surgery (HIPAID)

TypeinterventionalSponsorThe George InstituteRan2002 to 2004Enrolled1,000ConditionsOsteoarthritis, Hip, Arthroplasty, Replacement, Hip, Arthritis, RheumatoidArmsIbuprofen
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 5 syntheses or guidelines pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pharmacotherapy for the prevention of chronic pain after surgery in adults.The Cochrane database of systematic reviews · 2013
    Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Clinical and radiological outcomes of total hip arthroplasty in patients affected by Paget's disease: a combined registry and single-institution retrospective observational study.Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology · 2021
    Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

Marlene FransenThe George Institute for International Health, University of Sydney, Australia. mfransen@george.org.au
Craig Anderson
Jan Douglas
Stephen MacMahon
Bruce Neal
Robyn Norton
Mark Woodward
Ian D Cameron
Ross Crawford
Sing Kai Lo
Garnet Tregonning
Margaret Windolf
HIPAID Collaborative Group
The University of Sydney · AUThe George Institute for Global Health · AUDeakin University · AUJohns Hopkins University · USMiddlemore Hospital · NZQueensland University of Technology · AURoyal Prince Alfred Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo determine the benefits and risks of a non-steroidal anti-inflammatory drug (NSAID) as prophylaxis for ectopic bone formation in patients undergoing total hip replacement (or revision) surgery.

designDouble blind randomised placebo controlled clinical trial, stratified by treatment site and surgery (primary or revision).

setting20 orthopaedic surgery centres in Australia and New Zealand.

participants902 patients undergoing elective primary or revision total hip replacement surgery.

intervention14 days' treatment with ibuprofen (1200 mg daily) or matching placebo started within 24 hours of surgery.

main outcome measuresChanges in self reported hip pain and physical function 6 to 12 months after surgery (Western Ontario and McMaster University Arthritis index).

resultsThere were no significant differences between the groups for improvements in hip pain (mean difference -0.1, 95% confidence interval -0.4 to 0.2, P = 0.6) or physical function (-0.1, -0.4 to 0.2, P = 0.5), despite a decreased risk of ectopic bone formation (relative risk 0.69, 0.56 to 0.83) associated with ibuprofen. There was a significantly increased risk of major bleeding complications in the ibuprofen group during the admission period (2.09, 1.00 to 4.39).

conclusionsThese data do not support the use of routine prophylaxis with NSAIDs in patients undergoing total hip replacement surgery.

trial registrationNCT00145730.

Indexed as

Anti-Inflammatory Agents, Non-SteroidalArthroplasty, Replacement, HipAustraliaDouble-Blind MethodFemaleHumansIbuprofenMaleMiddle AgedNew ZealandOssification, HeterotopicPatient CompliancePostoperative CarePostoperative PainRisk FactorsTreatment OutcomeAnti-Inflammatory Agents, Non-SteroidalIbuprofen

Identifiers

PMID16885182
PMCPMC1562471
OpenAlexW1567949468

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.